TORONTO, May 02, 2018 -- YAMANA GOLD INC. (TSX:YRI) (NYSE:AUY) (“Yamana” or the “Company”) declares a second quarter 2018 dividend of $0.005 per share. Shareholders of record at the close of business on June 29, 2018 will be entitled to receive payment of this dividend on July 13, 2018. The dividend is an “eligible dividend” for Canadian tax purposes.
About Yamana
Yamana is a Canadian-based gold producer with significant gold production, gold development stage properties, exploration properties, and land positions throughout the Americas including Canada, Brazil, Chile and Argentina. Yamana plans to continue to build on this base through existing operating mine expansions, throughput increases and optimization initiatives, development of new mines, the advancement of its exploration properties and, at times, by targeting other gold consolidation opportunities with a primary focus in the Americas.
FOR FURTHER INFORMATION PLEASE CONTACT:
Investor Relations and Corporate Communications
416-815-0220
1-888-809-0925
Email: [email protected]
(All amounts are expressed in United States dollars unless otherwise indicated.)


SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
SK Hynix’s $28B U.S. IPO Draws Strong Demand as AI Chip Boom Fuels Investor Interest
Telenor to Buy Controlling Stake in Bahnhof in $630 Million Broadband Deal
Apple Tests China's CXMT Memory Chips as DRAM Maker Gains Global Market Share
Netflix, Disney, YouTube Eye FIFA World Cup TV Rights in Multi-Billion Dollar Battle
Zhipu AI Stock Jumps on Report of Custom AI Chip Development Plans
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
Wolfspeed Sues Navitas Over GaN and SiC Patent Infringement
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge
OpenAI GPT-5.6 Set for Wider Release After U.S. Commerce Approval, Report Says
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow
Chinese Chip Stocks Jump as Apple Reportedly Tests CXMT Memory Chips for China Devices 



